Literature DB >> 9186068

Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.

M Haas1.   

Abstract

IgA nephropathy (IgAN) may present with a wide variety of histologic patterns on renal biopsy, ranging from a minimal lesion to a diffuse proliferative glomerulonephritis (GN). The histologic features of 244 cases of IgAN (not including Schönlein-Hanoch nephritis) diagnosed between 1980 and 1994 were reviewed, and each case was subclassified using the following, relatively simple histologic classification scheme: subclass I (39 cases): minimal or no mesangial hypercellularity, without glomerular sclerosis; subclass II (18 cases): focal and segmental glomerular sclerosis without active cellular proliferation; subclass III (110 cases): focal proliferative GN; and subclass IV (42 cases): diffuse proliferative GN; and subclass V (35 cases): any biopsy showing > or = 40% globally sclerotic glomeruli and/or > or = 40% estimated cortical tubular atrophy or loss. Subsequent analysis of renal survival in 109 patients who underwent biopsy before or during 1992 for whom such data were available showed a strong, statistically significant correlation between histologic subclass and renal survival, with an order I, II (greatest survival) > III > IV, V. Crescents were a significant negative prognostic indicator for renal survival in subclass III (but not in subclass IV), and interstitial expansion was a negative prognostic indicator in subclasses III and IV, although the statistical significance of these were not maintained after controlling for serum creatinine at the time of biopsy. The presence of peripheral glomerular capillary deposits ultrastructurally had no prognostic significance. With respect to clinical presentation, hypertension (systolic blood pressure > or = 130 mm Hg and diastolic blood pressure > or = 90 mm Hg) and proteinuria of > or = 2.0 g/24 hr were significant negative prognostic indicators for renal survival, even when controlling for serum creatinine at the time of renal biopsy. The presence of gross hematuria correlated significantly with increased renal survival by univariate analysis, but not when controlling for serum creatinine at the time of renal biopsy. The findings of this study confirm the wide variety of clinical and histopathologic presentations of IgAN, and indicate the utility of the proposed histologic classification schema in assessing a patient's likelihood of ultimately developing end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186068     DOI: 10.1016/s0272-6386(97)90456-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  99 in total

1.  Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.

Authors:  Aron Chakera; Clare MacEwen; Shubha S Bellur; La-Or Chompuk; Daniel Lunn; Ian S D Roberts
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

2.  High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors:  F M Rasche; F Keller; P M Lepper; C Aymanns; W Karges; L-C Sailer; L von Müller; D Czock
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  The contribution of B cells to renal interstitial inflammation.

Authors:  Florian Heller; Maja T Lindenmeyer; Clemens D Cohen; Ulrike Brandt; Dan Draganovici; Michael Fischereder; Matthias Kretzler; Hans-Joachim Anders; Thomas Sitter; Isabella Mosberger; Dontscho Kerjaschki; Heinz Regele; Detlef Schlöndorff; Stephan Segerer
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes.

Authors:  Y Tan; J-J Zhang; G Liu; H Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

5.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

6.  C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.

Authors:  Lu Liu; Ying Zhang; Ximei Duan; Qi Peng; Quan Liu; Yali Zhou; Songxia Quan; Guolan Xing
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

7.  Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study.

Authors:  Jae Yeon Kim; Hyeok Choi; Minyoung Kevin Kim; Soo Bin Lee; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2019-08-01       Impact factor: 2.631

8.  Treatment of IgA nephropathy of adults presented by nephrotic syndrome.

Authors:  Senija Rasić; Snjezana Uncanin; Kenana Aganović; Ismar Rasić; Jasminka Dzemidzić; Alma Muslimović
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

9.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

10.  Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy.

Authors:  Nobuo Tsuboi; Tetsuya Kawamura; Kentaro Koike; Hideo Okonogi; Keita Hirano; Akihiko Hamaguchi; Yoichi Miyazaki; Makoto Ogura; Kensuke Joh; Yasunori Utsunomiya; Tatsuo Hosoya
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.